Sunesis Biopharma Private Limited - Company Profile

It is a chemicals private limited company based in Jaipur, Rajasthan, India, established in 2009.
2009 Jaipur, Rajasthan, India Struck Off
Last Updated:
About Sunesis Biopharma Private Limited

Sunesis Biopharma Private Limited, a struck off private limited company, was established on 18 August 2009 in Jaipur, Rajasthan, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24232RJ2009PTC029622. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Deepak Sharma (Director), Ritu Raj Bhardwaj (Director). Its latest AGM occurred on 30 September 2010, with the balance sheet filed on 31 March 2010. It is based at 61, Binjari Marg, Anand Vihar-A, Dadi Ka Phatak, Jhotwara, Jaipur, Rajasthan, 302012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232RJ2009PTC029622

  • Registration Number

    029622

  • Incorporation Date

    18 August 2009

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 6 Months
  • Last Filing with ROC 31 Mar 2010
Company report

Sunesis Biopharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sunesis Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sunesis Biopharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Deepak Sharma Director 18 Aug 2009 Current
Ritu Raj Bhardwaj Director 18 Aug 2009 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sunesis Biopharma.

Enhance accessibility to Sunesis Biopharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sunesis Biopharma revenue growth over time
Sunesis Biopharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sunesis Biopharma?

Unlock access to Sunesis Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sunesis Biopharma?

Unlock and access historical data on people associated with Sunesis Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sunesis Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunesis Biopharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sunesis Biopharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Sunesis Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Sunesis Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Jaipur. was documented.

  • Director Appointment

    Progress on Deepak Sharma was appointed as a Director was appointed as a Director on 18 Aug 2009 & has been associated with this company since 16 years 6 months . was documented.

  • Director Appointment

    Ritu Raj Bhardwaj was appointed as a Director was appointed as a Director on 18 Aug 2009 & has been associated with this company since 16 years 6 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Sunesis Biopharma Private Limited was registered on 18 Aug 2009 with Roc Jaipur & aged 16 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sunesis Biopharma Private Limited?

The CIN of Sunesis Biopharma Private Limited is U24232RJ2009PTC029622.

Where is Sunesis Biopharma Private Limited headquartered?

Sunesis Biopharma Private Limited is headquartered at 61, Binjari Marg, Anand Vihar-A, Dadi Ka Phatak, Jhotwara, Jaipur, Rajasthan, 302012.

When was Sunesis Biopharma Private Limited incorporated?

Sunesis Biopharma Private Limited was incorporated on 18 August 2009.

Who are the current directors of Sunesis Biopharma Private Limited?

The current directors of Sunesis Biopharma Private Limited are

What is the primary industry of Sunesis Biopharma Private Limited?

The primary industry of Sunesis Biopharma Private Limited is Chemicals.

Is Sunesis Biopharma Private Limited a listed company?

Sunesis Biopharma Private Limited is unlisted.

What is the capital structure of Sunesis Biopharma Private Limited?

The authorized capital of Sunesis Biopharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available